NSAIDs Shows No Advantage over CBT in Knee Osteoarthritis
JAMA Internal Medicine reports on a controlled clinical trial of knee osteoarthritis patients wherein meloxicam responses were not significantly or clinically superior to placebo or CBT (after placebo).


